The bricks are coming off the market's shoulders, and these five hot biotech stocks are among the top beneficiaries. More
- Poll of the Day
Biotech stocks are great and everyone should own them.
Pharmaceuticals and biotechs have been too hot for their own good, fueled by increasingly iffy M&A and an oddly high level of IPO activity. More
Unfortunately, a bet on MNKD stock right now isn't a bet on the potential of Afrezza. But sooner or later, these facts will be reflected in MannKind shares. More